Literature DB >> 3305455

Blastogenic responses and the release of interleukins 1 and 2 by spleen cells obtained from rat skin allograft recipients administered with 15-deoxyspergualin.

K Nemoto, F Abe, T Nakamura, M Ishizuka, T Takeuchi, H Umezawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3305455     DOI： 10.7164/antibiotics.40.1062

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  9 in total

1.  Therapeutic effect of 15-deoxyspergualin on the progression of lupus nephritis in MRL mice. I. Immunopathological analyses.

Authors:  S Ito; M Ueno; M Arakawa; T Saito; T Aoyagi; M Fujiwara
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

Review 2.  Antitumor antibiotics discovered and studied at the Institute of Microbial Chemistry.

Authors:  T Takeuchi
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

3.  Mechanism of action of 15-deoxyspergualin. I. Suppressive effect on the induction of alloreactive secondary cytotoxic T lymphocytes in vivo and in vitro.

Authors:  K Nishimura; T Tokunaga
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

4.  Suppression of host resistance against Listeria monocytogenes infection by 15-deoxyspergualin in mice.

Authors:  A Nakane; A Numata; T Minagawa
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

5.  Enhanced liver regeneration in rats treated with 15-deoxyspergualin alone and in combination with FK 506.

Authors:  M Ohtake; N Okamura; T Sakaguchi; T Aono; S Koyama; K Tsukada; K Yoshida; T Muto
Journal:  Gastroenterol Jpn       Date:  1993-04

6.  Immunosuppressant deoxyspergualin induces apoptotic cell death in dividing cells.

Authors:  C Odaka; E Toyoda; K Nemoto
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

7.  Deoxyspergualin preferentially inhibits the growth and maturation of anti-CD40-activated surface IgD+ B lymphocytes.

Authors:  K Morikawa; K Nemoto; T Miyawaki; S Morikawa
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

8.  Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.

Authors:  S Jung; K V Toyka; H P Hartung
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

9.  The immunosuppressant 15-deoxyspergualin [correction of 1,5-deoxyspergualin] reveals commonality between preT and preB cell differentiation.

Authors:  B Wang; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.